KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Non-Current Liabilities (2016 - 2025)

Jazz Pharmaceuticals has reported Other Non-Current Liabilities over the past 14 years, most recently at $124.5 million for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 43.76% to $124.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124.5 million through Dec 2025, up 43.76% year-over-year, with the annual reading at $124.5 million for FY2025, 43.76% up from the prior year.
  • Other Non-Current Liabilities was $124.5 million for Q4 2025 at Jazz Pharmaceuticals, up from $108.9 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $144.0 million in Q4 2022 and troughed at $86.6 million in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $123.3 million (2022), against an average of $116.7 million.
  • Biggest five-year swings in Other Non-Current Liabilities: dropped 29.41% in 2024 and later surged 43.76% in 2025.
  • Tracing JAZZ's Other Non-Current Liabilities over 5 years: stood at $137.9 million in 2021, then grew by 4.43% to $144.0 million in 2022, then decreased by 14.78% to $122.7 million in 2023, then decreased by 29.41% to $86.6 million in 2024, then soared by 43.76% to $124.5 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $124.5 million, $108.9 million, and $93.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.